Brief: Annexin Pharmaceuticals Reports Q1 Loss Of SEK 8 Mln
May 14 (Reuters) - Annexin Pharmaceuticals AB (publ) ANNX.ST: REPORTS Q1 2025 RESULT OF -7,974 TSEK Source text: ID:nMFNbqzd2D Further company coverage: ANNX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed